Close

Developer

Close

Publisher

Close

Search

Where I must search?


Submitted: Accepted: Online:

Abstract:


Acknowledgements:

Contributions:

Conflict of Interest:

Funding Information:

Ethical Approval:

Informed Consent:

Open Access:

How to Cite:


Contact info:


Display fulltext article (PDF)
POR Subscription
POR Sale
POR Other
Service
Company
Trademark
Details
Homepage
Operation system
RedHat Inc.
logo
CentOS 7 Linux
HTTP server
The Apache Software Foundation
logo
HTTP Server V.2.2.3.
Script interpreter
Zend Technologies
logo
PHP 7.3
Database server
MariaDB Foundation
logo
MariaDB 10.1
PDF format
Adobe Systems Inc.
logo
Adobe PDF
Software+hardware
Bioinformat-X Bt.
logo
Development, operation
POR Description

Pathology & Oncology Research (POR) is an interdisciplinary journal at the interface of pathology and oncology, including the preclinical and translational research, diagnostics and therapy. Furthermore, POR offers an international forum for the rapid communication of reviews, original research, critical and topical reports with excellence and novelty. Published quarterly, POR is dedicated to keeping scientists informed of developments in its focused biomedical fields which span the gap between basic research and clinical medicine. A special aim of POR is to promote publishing activity in pathology and oncology of colleagues in the Central and East European region. The journal will interest pathologists, and a broad range of experimental and clinical oncologists, and related experts. Pathology & Oncology Research is supported by distinguished international advisory board and the Arányi Foundation for modern pathology.

  • Presents research, reviews and topical reports at the interface of pathology and oncology
  • Coverage spans the gap between basic research and clinical medicine
  • Promotes the publication of pathology and oncology research by specialists in Central and Eastern Europe
  • 95% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Publishing model: Hybrid
Impact factor: 2.433 (2019)
Five year impact factor: 1.973 (2019)
Available: 1995-2020
Volumes: 25
Issues: 96
Articles: 2326
Open access: 122
Submission to first decision: 147 days
Submission to acceptance: 209 days
Downloads: 97,058 (2018)
POR Editorial board

SCIENTIFIC EDITORS
László KOPPER MD PhD DSczsulacz@upcmail.hu
József TÍMÁR MD PhD DScjtimar@oncol.hu

EDITORIAL OFFICE
1st Institute of Pathology and Experimental Cancer Research
Semmelweis University, Budapest
Üllôi út 26, H1085 Budapest, Hungary
zsulacz@upcmail.hu
Science Press Publishing Ltd.Tel: +36-1-1171070
Fax: +36-1-1171074

PRINTING EDITOR
Judit NAGY
Science Press Publishing Ltd.
Hermina út 57-59, H1146 Budapest, Hungary
Tel: +36-1-2517531
Fax: +36-1-2517339

ADVISORY BOARD
Albini AIRCCS Multimedica, Milano, Italy Zsolt ArgényiUniversity of Washington, Seattle, Washington, USA Mikael BjörkstedtKarolinska Institute, Stockholm, Sweden
Fred Bosman, University of Lausanne, Switzerland Gábor CserniBács-Kiskun County Teaching Hospital, Kecskemét, Hungary Helmut DenkUniversity of Graz, Austria
Mary JC HendrixShepherd University, Shepherdtown, WVA, USA Kenneth V. HonnWayne State University, Detroit, MI, USA Sirpa JalkanenUniversity of Turku, Finnland
András JeneySemmelweis University, Budapest, Hungary Andras KhoorMayo Clinic, Jacksonville, FL, USA Ilona KovalszkySemmelweis University, Budapest, Hungary
Tibor KrenácsSemmelweis University, Budapest, Hungary Thomas KrauszThe University of Chicago, Chicago, Illinois, USA Janina KulkaSemmelweis University, Budapest, Hungary
Károly LapisSemmelweis University, Budapest, Hungary András MatolcsySemmelweis University, Budapest, Hungary Yukio NishimuraKyushu University, Fukuoka, Japan
Robert PirkerUniversity of Vienna, Austria Helmuth PopperUniversity of Graz, Austria Lajos PusztaiThe University of Texas MD Anderson Cancer Center, Houston TX, USA
Avraham RazMichigan Cancer Foundation, Detroit, MI, USA Ales RyskaCharles University, Hradec Kralove, Czech Republic Zoltán SápiSemmelweis University, Budapest, Hungary
Zsuzsa SchaffSemmelweis University, Budapest, Hungary Péter SótonyiSemmelweis University, Budapest, Hungary Zoltan SzallasiBoston Children’s Hospital, Dana-Farber/Harvard Cancer Center, Boston, MA, USA

POR Editor in chief

EDITORS-IN-CHIEF

László KOPPER, Semmelweis University, Budapest, Hungary
József TÍMÁR, Semmelweis University, Budapest, Hungary

FOUNDING EDITORS

Zsolt OROSZ, Oxford University Hospitals, Oxford, UK
Judit NAGY, Professional Publishing Hungary Co., Budapest, Hungary

MANAGING EDITOR

Anna SEBESTYÉN, Semmelweis University, Budapest, Hungary

EDITORIAL CONSULTANT

Andrea LADÁNYI, National Institute of Oncology, Budapest, Hungary

CONTACT

Phone/Fax: +36-1-215-6921
E-mail: jtimar@gmail.hu
POR Editorial
2nd Institute of Pathology, Semmelweis University, Budapest
Address: Üllôi út 26, 1085 Budapest, Hungary
Phone: +36-1-1170891
Fax: +36-1-1170891
Email: poresebanna@gmail.com
POR Publisher

Arányi Lajos Foundation was established to commemorate the 150th anniversary of the first Pathology Department in Hungary which was privately initiated by professor Lajos Arányi. His idea (complementary private support for state-financed medical institutions) is intended to be revitalized by the founders of "Arányi Lajos Foundation for Modern Pathology". The main goals of the Arányi Lajos Foundation are to attract public donations for infrastructural and methodologic developments in pathology and oncology and to support publication activities. The support of the Foundation to Pathology Oncology Research is gratefully acknowledged. Donations can be sent to:

Arányi Lajos Alapítvány/POR
OTP 11709002-20088868.
OTP National Saving and Commercial Bank Ltd.
1095 Budapest, XI Tinodi u. 9-11.

Pathology Oncology Research is published quarterly by Arányi Lajos Foundation. The subscription to Volume 1 (4 issues) is US$ 80/40 (institute/personal). Subscriptions must be prepaid by cheque or credit card and an address given for delivery. Prices include packing and postage by airmail to subscribers. Further informations: dr. Judit Nagy (Publisher; see above).

This journal accepts advertising (managed by the Publisher). We also publish abstracts, proceedings and supplements on behalf of academic and corporate sponsors (please contact one of the Editors).

(c) 1995 Science Press Publishing Ltd. Budapest., (c) 1996-2001 WB Saunders Ltd., (c) 2002-2019 Springer Netherlands, (c) 1995-2020 Arányi Lajos Foundation. All rights reserved; no part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the Publisher.

ISSN 1219-4956

POR Submitting manuscripts

Having received the manuscript, an Acknowledgement Letter is sent to the corresponding author, including the manuscript number to be used for further communications. One of the editors assigns manuscripts to experts (two reviewers). Authors are encouraged to give names and addresses of persons outside their own institutions who might be considered as reviewers for their manuscript. Authors can also request to exclude particular reviewers. The review process is intended to be finished within 30 days. Four levels of evaluation are used for manuscripts: accepted; acceptable with minor revision; acceptable with major revision; rejected.

Revised manuscripts should be submitted with one original and the electronic version, including figures, within 3 months (otherwise the manuscript will be treated as a new submission). Revised manuscripts must be accompanied by a letter in which the authors respond to each issue raised by the reviewers (either indicating revision or responding to the reviewers' comments). Changes should be marked on one copy in red ink.

It is encouraged to submit the manuscripts in electronic format (on CD or by E-mail). Text and table(s) must be in MSWord. Electronic illustration (computer-generated figures) is also required (in MS.ppt or in common graphic format using high resolution). Submit illustrations in separate file(s). Preferred graphic softwares are: Adobe Illustrator; Aldus Freehand. To avoid heterogeneity, the preferred character font is Times. On the CD, indicate the title and authors as well as the operating system and word processing program need to generate the file. (The file name is the last name of the first author, followed by a period plus the three letter extension, POR). It is essential that CD(s) be accompanied by hard copy printout. The CD and the paper copy must be identical.

POR Organizing the Manuscript

Editorial policy

POR is devoted especially to basic problems of Pathology and Oncology, together with related clinical and clinicopathological aspects; is a forum for high quality papers from all over the world, including, naturally, our closer geographical area; entertains teaching material from internationally recognized experts. (The only restriction: manuscripts must be in English.

Forms/Categories of Publications

POR publishes Editorials, Reviews or Minireviews, Articles, Reports, Short Communications, Case Reports, Seminars (Special Reports or Postgraduate Courses), News (or Market News), and Letters to the Editor.

Editorials - Editorials present opinions on any subject relevant to POR’s concerns, including those which discuss the importance of findings published in the same issue. Editorials are usually the responsibility of editors and Advisory Board members but other submissions will also be considered. The length of the Editorial is about 1000-1500 words.

Reviews/Minireviews - Cover a specific topic using the same policy as described for Editorials (mainly invited). Conditions for reviews are the same as for articles. The length of a Minireview should be less than 3000 words, but is negotiable.

Articles - Report original findings of significant importance. They contain around 4000 words (without abstract, reference list or legend for figures and tables). Maximum number of figures and tables: eight.

Reports - Describe important results (not preliminary) which do not need extensive formatting. The length is about 2500 words (with exceptions as described for articles). Maximum number of figures and tables: four.

Short Communications - Serve for rapid publication of even preliminary results of general interest. It should contain 750 words or less (with exceptions as described for articles). Maximum number of figures or tables: two.

Case reports - Should include clinically significant data, a maximum of 1000 words and two figures and/or tables.

Seminars (postgraduate courses) - The purpose is to give a state of the art (up-to-date) overview of a specific topic in pathology or oncology by an invited author. Nevertheless, non-invited manuscripts can also be accepted (in such case a preliminary contact with the Editorial Office is recommended, both to receive technical details and also to discuss the matter of acceptance). Maximum number of figures and tables: eight.

News (Market News) - Usually provided by the editors but is open for any professionals who want to publish scientific and market news (congresses, exhibitions, books, while publication of the contents of other journals can be negotiated on a mutual basis).

Letters to the Editor - Letters (not more than 500 words) provide a forum to express opinions about materials appearing in POR. Relevant references should be included (in case of citation of others'work). Usually, Letters are referred to the authors of commented papers and a response can also be published. Only one figure or table is permitted.

Copyright - Acceptance of the manuscript should indicate the acknowledgement of copyright release to the publisher (Arányi Lajos Foundation). The "Acknowledgement of Copyright Release" (accompanies the proof) signed by the corresponding author also implies that it has been agreed by all named authors, the manuscript contains unpublished work/results, and is not under consideration, in whole or in part, for publication elsewhere (in any language).

Advice on permissions - Owing to problems in gaining permission to reproduce and store material electronically, authors are requested to avoid the use of previously published material. Authors who do plan to reproduce previously published work MUST obtain permission from the copyright holder (usually the publisher), granting this permission. Copies of ALL permission letters should accompany the manuscript. If material from the author’s own published work is to be used, permission should still be obtained from the publisher. We require non-exclusive rights for all languages and also need the right to store and publish the material electronically. Necessary permissions MUST be obtained by the author. As a matter of courtesy, permission should also be requested from the author of the original material. A credit line giving the full source of the material should be included in the manuscript (e.g. in the legend for a figure or a footnote to a table).

Submission and review of manuscript

One original and two complete copies as well as the electronic version of manuscript should be submitted to the Editors-in-Chief:

László KOPPER, MD, PhD, DSc
1st Institute of Pathology and Experimental Cancer Research
Semmelweis University, Budapest
Üllôi út 26, Budapest, H-1085, Hungary
Tel: (36) (1) 317-0891
Fax: (36) (1) 317-0891
E-mail: zsulacz@upcmail.hu

József TÍMÁR, MD, PhD, DSc
Department of Tumor Progression
National Institute of Oncology
Semmelweis University, Budapest
Ráth Gy. u. 7-9, Budapest, H-1122, Hungary
Tel: (36) (1) 224-8786
Fax: (36) (1) 224-8706
E-mail: jtimar@oncol.hu

or to the Regional Editors:

Ian A CREE, MD, PhD (for UK)
Translational Oncology Research Centre
Department of Histopathology
Michael Darmady Laboratory
Queen Alexandra Hospital, Cosham
Portsmouth PO6 3LY
Phone: (44) (0) 2392-286-458
Fax: (44) (0) 2392-286-493.
E-mail: ian.cree@port.ac.uk

Mary JC HENDRIX, PhD (for USA)
President and Scientific Director
Children's Memorial Institute for Education and Research
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
2300 Children's Plaza, Box 222
Chicago, Illinois 60614-3394
Phone: (1) 773-755-6528
Fax: (1) 773-755-6534
E-mail: mjchendrix@childrensmemorial.org

Having received the manuscript, an Acknowledgement Letter is sent to the corresponding author, including the manuscript number to be used for further communications. One of the editors assigns manuscripts to experts (two reviewers). Authors are encouraged to give names and addresses of persons outside their own institutions who might be considered as reviewers for their manuscript. Authors can also request to exclude particular reviewers. The review process is intended to be finished within 30 days. Four levels of evaluation are used for manuscripts: accepted; acceptable with minor revision; acceptable with major revision; rejected.

Revised manuscripts should be submitted with one original and the electronic version, including figures, within 3 months (otherwise the manuscript will be treated as a new submission). Revised manuscripts must be accompanied by a letter in which the authors respond to each issue raised by the reviewers (either indicating revision or responding to the reviewers' comments). Changes should be marked on one copy in red ink.

It is encouraged to submit the manuscripts in electronic format (on CD or by E-mail). Text and table(s) must be in MSWord. Electronic illustration (computer-generated figures) is also required (in MS.ppt or in common graphic format using high resolution). Submit illustrations in separate file(s). Preferred graphic softwares are: Adobe Illustrator; Aldus Freehand. To avoid heterogeneity, the preferred character font is Times. On the CD, indicate the title and authors as well as the operating system and word processing program need to generate the file. (The file name is the last name of the first author, followed by a period plus the three letter extension, POR). It is essential that CD(s) be accompanied by hard copy printout. The CD and the paper copy must be identical.

Organizing the manuscript

Title page - Title should be 15 words (or less), informative, without subtitles. Give full name and affiliation of each author and the name and mailing address, with fax and phone numbers of the author to whom correspondence and reprint requests are to be sent. Provide a running title of not more than 50 characters. Research support can also be indicated as a footnote to the title.

Abbreviations/acronyms - Avoid if it is possible. If not, list and define them. Use JBC format for standard scientific abbreviations.

Key words - List 3-6 key words (from Index Medicus whenever possible) for indexing.

Abstract/Summary - Do not exceed 250 words for Articles, Reports and Seminars, 150 words for Short Communications and Case Reports. State briefly the aims of the study, the main question(s) and approach(es) as well as the most important results and conclusions. The abstract should be informative without reference to the manuscript.

Introduction - Provides background data which stimulated and/or initiated the study. The most relevant results from the literature should be summarized.

Materials and Methods - Should be sufficiently detailed in order to be repeated by other researchers.

Results - All important results should be given here avoiding repetition of data in the text and in the tables/figures. "Significant" is used only when results are statistically significant (P-value or confidence interval).

Discussion - Serves to interpret the results without repeating. There is no need for separate discussion in Short Communications or Case Reports.

Reference - References must be numbered and arranged according to the first citation in the text. The following formats must be used:

for periodicals
1. Boom H, Bim GH, Bam D: Do not take yourself too seriously. Phantasy 1: 1-9, 1996

for books
2. Boom H: Do not take yourself too seriously. Phantasy Publ Co, NewYork-London-Budapest, 1996

for articles in books
3. Boom H: Do not take yourself too seriously. In: Who is who and why. (Eds: Bim GH and Bam D), Phantasy Publ Co, 1996, pp. 1-9

In the text references should be cited by numbers in superscript or – if it is absolutely necessary – by the author's name with numbers (also in superscript). E.g. Boom1 or Boom and Bam4 or Boom et al.5
"In press" can be used (in place of volume and page number) only for papers by the author(s) that have been accepted for publication.
Cite submitted papers and unpublished data in the text only (but only when it is unavoidable).

Tables, Figures and their Legends - Should stand alone, be self-explanatory. Tables should be numbered consecutively (e.g. Table 3). Type tables double-spaced with titles and legends (footnote), and headings for columns. Figures (photographs, drawings, graphics) should be numbered consecutively (Fig 3 – to separate different parts of the figure/panel use capital letters). The preferred character font is Times. For computer printouts use laser or inkjet printers, but not dot-matrix. Three sets of each of the figures should be submitted. The back of each figure should show the authors name, the figure number and "top" of the figure should be indicated. Photographs should be clear, glossy prints (do not send negatives or figures on disk). For artwork use black ink. High quality color photos and illustrations are accepted without charge. Each color material (three sets) should be accompanied by one high quality positive slide. Figures should be sized to fit one columns (8 cm) or two column (16.7 cm); the maximum plate size is 16.7 cm x 23.7 cm. Use separate page for Legend to Figure(s).

Typescript - Manuscript should be double spaced, pages numbered consecutively with new pages for each section (Title page is page 1).
POR uses Webster's New Collegiate Dictionary as the standard for spelling.
Units should satisfy International System of Units (SI).
Specific products and companies should be identified to ensure exact recognition.

Proofs - The Publisher sends a set of page proofs to the corresponding author. Authors should check the proofs carefully according to the attached instructions and return the original proof within 48 hours (e.g. by surface mail).

POR Rights

Arányi Lajos Foundation was established to commemorate the 150th anniversary of the first Pathology Department in Hungary which was privately initiated by professor Lajos Arányi. His idea (complementary private support for state-financed medical institutions) is intended to be revitalized by the founders of "Arányi Lajos Foundation for Modern Pathology". The main goals of the Arányi Lajos Foundation are to attract public donations for infrastructural and methodologic developments in pathology and oncology and to support publication activities. The support of the Foundation to Pathology Oncology Research is gratefully acknowledged. Donations can be sent to:

Arányi Lajos Alapítvány/POR
OTP 11709002-20088868.
OTP National Saving and Commercial Bank Ltd.
1095 Budapest, XI Tinodi u. 9-11.

Pathology Oncology Research is published quarterly by Arányi Lajos Foundation. The subscription to Volume 1 (4 issues) is US$ 80/40 (institute/personal). Subscriptions must be prepaid by cheque or credit card and an address given for delivery. Prices include packing and postage by airmail to subscribers. Further informations: dr. Judit Nagy (Publisher; see above).

This journal accepts advertising (managed by the Publisher). We also publish abstracts, proceedings and supplements on behalf of academic and corporate sponsors (please contact one of the Editors).

(c) 1995 Science Press Publishing Ltd. Budapest., (c) 1996-2001 WB Saunders Ltd., (c) 2002-2019 Springer Netherlands, (c) 2002 Arányi Lajos Foundation. All rights reserved; no part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the Publisher.

ISSN 1219-4956

POR Registration

Send

POR Login

Send

POR Forgotten

Send

POR My data

Send

POR Upload
Send
POR List
POR Exit
POR Institutions
  1. Algeria, Algiers
  2. USTHB, Faculty of Biological Sciences
  3.     - USTHB, Faculty of Biological Sciences, Laboratory of Dynamics and Biodiversity
  4.     - USTHB, Faculty of Biological Sciences, Laboratory of Molecular and Cellular Biology
  5.     -     - USTHB, Faculty of Biological Sciences, Laboratory of Molecular and Cellular Biology, Unit of Genetics
  6.     - USTHB, Faculty of Biological Sciences, LOBEM
  7. Algeria, Batna
  8. Anti-cancer center of Batna
  9. Batna 1 University
  10.     - Batna 1 University, Faculty of Sciences
  11. Batna 2 University
  12.     - Batna 2 University, Faculty of Medicine
  13. LAM Laboratory
  14. University Hospital Center
  15.     - University Hospital Center, Epidemiology Unit
  16. Algeria, Maghnia
  17. Surgery Clinic AVICENE
  18. Algeria, Oran
  19. Centre Hospitalier d’Oran
  20. Université d’Oran
  21.     - Université d’Oran, Faculté de Médecine
  22.     -     - Université d’Oran, Faculté de Médecine, Département de Pharmacie
  23.     - Université d’Oran, Faculté des sciences de la nature et de la vie
  24.     -     - Université des Sciences et de la Technologie d’Oran- Mohamed BOUDIAF-USTOMB, Faculté des sciences de la nature et de la vie, Département de Génétique Moléculaire Appliquée, Laboratoire de Génétique Moléculaire et Cellulaire
  25. Algeria, Rouiba
  26. University of Algiers, School of Medicine
  27.     - University of Algiers, School of Medicine, Public Hospital Academic Medical Oncology Services
  28. Algeria, Tlemcen
  29. Tlemcen Hospital
  30.     - Tlemcen Hospital, Division of Obstetrics and Gynecology
  31. University ABOU-BEKR BELKAÏD
  32.     - University ABOU-BEKR BELKAÏD, Department of Molecular and Cellular Biology
  33.     -     - University ABOU-BEKR BELKAÏD, Department of Molecular and Cellular Biology, Laboratory of Physiology and Biochemistry of Nutrition
  34. University of Tlemcen
  35.     - University of Tlemcen, Faculty of Engineering
  36.     - University of Tlemcen, Faculty of Sciences
  37.     -     - University of Tlemcen, Faculty of Sciences, Department of Molecular and Cellular Biology
  38. Argentina, La Plata
  39. Interzonal Hospital of San Martín
  40.     - Interzonal Hospital of San Martín, Service of Pathology
  41. National University of La Plata
  42.     - National University of La Plata, Faculty of Medical Sciences
  43.     -     - Facultad de Ciencias Médicas, UNLP, Centro de Investigaciones Inmunológicas Básicas y Aplicadas (CINIBA)
  44.     -     - National University of La Plata, Faculty of Medical Sciences, Department of Pathology
  45.     - National University of La Plata, IMBIOLP
  46.     - University of La Plata, Faculty of Veterinary Genetics
  47.     -     - University of La Plata, Faculty of Veterinary Genetics, IGEVET-CONICET (Institute of Veterinary Genetics-National Council of Scientific and Technical Investigations)
  48. Australia, Adelaide
  49. Dame Roma Mitchell Cancer Research Laboratories
  50. Flinders University
  51.     - Flinders Medical Centre
  52.     -     - Flinders Medical Centre, Urology Unit
  53.     - Flinders University, Flinders Centre for Innovation in Cancer
  54. Repatriation General Hospital
  55.     - Repatriation General Hospital, Urology Unit
  56.     - South Australia Prostate Cancer Clinical Outcomes Collaboration
  57. Royal Adelaide Hospital
  58.     - Royal Adelaide Hospital, SA Pathology
  59. University of Adelaide
  60.     - University of Adelaide, School of Medical Sciences
  61.     -     - University of Adelaide, Discipline of Surgery
  62.     -     - University of Adelaide, Freemasons Centre for Men’s Health
  63. University of South Australia
  64.     - University of South Australia, School of Medical Sciences
  65.     - University of South Australia, School of Pharmacy and Medical Sciences
  66.     - University of South Australia, School of Population Health
  67. Australia, Brisbane
  68. The University of Queensland
  69.     - The University of Queensland, Princess Alexandra Hospital
  70.     -     - The University of Queensland, Princess Alexandra Hospital, Department of Urology, Central Clinical Division
  71.     -     - The University of Queensland, Princess Alexandra Hospital, Diamantina Institute for Cancer, Immunology and Metabolic Medicine
  72.     - The University of Queensland, Royal Brisbane Hospital
  73.     -     - The University of Queensland, Royal Brisbane Hospital, Department of Surgery, Central Clinical Division
  74.     - University of Queensland Diamantina Institute
  75.     -     - University of Queensland Diamantina Institute, Translational Research Institute
  76. Australia, Canberra
  77. Australian National University, ANU College of Medicine, Biology and Environment
  78.     - Australian National University, ANU College of Medicine, Biology and Environment, Research School of Biology
  79.     -     - Australian National University, ANU College of Medicine, Biology and Environment, Research School of Biology, Division of Biomedical Science and Biochemistry
  80. Australia, Crawley
  81. The University of Western Australia
  82.     - The University of Western Australia, Faculty of Health and Medical Sciences
  83.     - The University of Western Australia, School of Pathology and Laboratory Medicine
  84. Australia, Joondalup
  85. Edith Cowan University
  86.     - Edith Cowan University, School of Medical Science
  87. Australia, Kogarah
  88. St George Hospital
  89. Australia, Nedlands
  90. QEII Medical Centre
  91.     - QEII Medical Centre, PathWest Laboratory Medicine
  92.     -     - QEII Medical Centre, PathWest Laboratory Medicine, Department of Anatomical Pathology
  93. Australia, New South Wales
  94. Royal Prince Alfred Hospital
  95.     - Royal Prince Alfred Hospital, Department of Radiation Oncology
  96. Royal Prince Alfred Hospital,, Department of Anatomical Pathology
  97. Australia, Perth
  98. Murdoch University
  99.     - Murdoch University, School of Veterinary and Life Science
  100. Sir Charles Gairdner Hospital
  101.     - Sir Charles Gairdner Hospital, Department of Medical Oncology
  102. The University of Notre Dame Australia
  103.     - The University of Notre Dame Australia, Institute for Health Research
  104. Australia, Randwick
  105. Prince of Wales Hospital
  106.     - Prince of Wales Hospital, Department of Pathology
  107. Australia, Sydney
  108. Garvan Institute of Medical Research
  109. Macquarie University Hospital
  110.     - Macquarie University Hospital, Australian School of Advanced Medicine
  111.     -     - Macquarie University Hospital, Australian School of Advanced Medicine, Department of Neurosurgery
  112. St Leonard’s
  113.     - St Leonard’s, RCPAQAP Molecular Genetics
  114. University of New South Wales
  115.     - St George Hospital
  116.     -     - St George Hospital, University of New South Wales, Department of Surgery
  117.     - University of New South Wales, School of Biotechnology and Biomolecular Sciences
  118.     - UNSW, Graduate School of Biomedical Engineering
  119.     -     - UNSW, Graduate School of Biomedical Engineering, Centre for Nanoscale Biophotonics
  120.     - UNSW, The George Institute for Global Health
  121. University of Sydney
  122.     - University of Sydney, School of Medical Sciences and Bosch Institute
  123.     -     - University of Sydney, School of Medical Sciences and Bosch Institute, Discipline of Pathology
  124. Australia, Ultimo
  125. University of Technology Sydney
  126.     - University of Technology Sydney, School of Mathematical and Physical Sciences
  127.     -     - University of Technology Sydney, School of Mathematical and Physical Sciences, Materials Analysis Unit
  128. Australia, Westmead